
Package Leaflet: Information for the User
Alopurinol Pensa 300 mg Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Alopurinol Pensa belongs to a group of medicines called enzyme inhibitors, which act by controlling the speed at which a certain chemical process occurs in the body. In this case, it produces a decrease in the level of uric acid in plasma and urine.
This medicine is used to prevent the onset of gout and other situations produced by excess uric acid in the body, such as kidney stones and certain types of kidney or metabolic diseases.
Do not take Alopurinol Pensa:
Warnings and precautions
Be particularly careful with this medicine:
You should stop treatment and contact your doctor as soon as possible if, while taking alopurinol, you experience any of the following symptoms:
It is possible that at the start of treatment with alopurinol, an acute gout attack may be triggered. Your doctor will recommend the use of certain medications to prevent this. In case of a gout attack, it is not necessary to stop treatment with alopurinol as long as an appropriate anti-inflammatory medication is used at the same time.
Severe skin reactions (hypersensitivity syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of alopurinol. Often, the rash can include ulcers in the mouth, throat, nose, genitals, and conjunctivitis (inflammation and redness of the eyes). These life-threatening skin reactions are often preceded by flu-like symptoms such as fever, headache, body aches. The rash can progress to blistering and generalized peeling of the skin. These severe skin reactions can be more frequent in people of Chinese, Thai, or Korean origin. Additionally, having chronic kidney failure can increase the risk in these patients. If you develop a skin rash or these skin symptoms, stop taking alopurinol and consult your doctor immediately.
The period of highest risk of severe skin reactions is during the first weeks of treatment.
If you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of alopurinol, you should not use alopurinol again at any time.
Other medicines and Alopurinol Pensa
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, especially the following. Your doctor may need to reduce the dose of your medicine or monitor you more closely because there is a higher risk of side effects when Alopurinol Pensa is taken at the same time as: 6-mercaptopurine (used to treat blood cancer), azathioprine (used to inhibit the immune system), vidarabine (for the treatment of viral infections), salicylates (aspirin, for the treatment of pain), uricosuric agents (probenecid, for the treatment of gout), chlorpropamide (for the treatment of diabetes), theophylline (for asthma), phenytoin (for epilepsy), ampicillin (antibiotic), amoxicillin (antibiotic), cyclophosphamide (for rheumatoid arthritis and some types of cancer), doxorubicin (for the treatment of certain types of lymphoma), bleomycin (for the treatment of some types of cancer), procarbazine (for the treatment of some types of cancer), mecloretamine (for the treatment of some types of cancer), cyclosporin (to prevent transplant rejection), coumarin anticoagulants to prevent clot formation, and didanosine (for the treatment of HIV) and captopril.
Administration of 6-mercaptopurine or azathioprine with alopurinol should be avoided. When 6-mercaptopurine or azathioprine is administered with Alopurinol Pensa, the dose of 6-mercaptopurine or azathioprine should be reduced because its activity will be prolonged. This could increase the risk of serious blood disorders. In this case, your doctor will closely monitor your blood count during treatment.
Go to your doctor immediately if you notice that you have any unexplained bruising, bleeding, fever, or sore throat.
If you take aluminum hydroxide at the same time, alopurinol may have a reduced effect, so there should be an interval of at least 3 hours between taking both medicines.
In the administration of alopurinol in combination with cytostatics (e.g., cyclophosphamide, doxorubicin, bleomycin, procarbazine, alkyl halides), blood disorders occur more frequently than when these active substances are administered alone.
Therefore, periodic blood tests should be performed.
Pregnancy, breastfeeding, and fertility
If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
The use of alopurinol is not recommended if you are pregnant.
Alopurinol passes into breast milk. The use of alopurinol is not recommended during the breastfeeding period.
Driving and using machines
Due to its side effects (drowsiness, dizziness, and coordination problems), this medicine may affect your ability to drive or operate machinery.
Do not drive, do not use tools or machines until you are reasonably sure that the medicine does not limit your abilities.
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Usually, your doctor will start treatment with alopurinol at a low dose (e.g., 100 mg/day) to reduce the risk of possible side effects. Your dose will be increased if necessary.
The score line is only for breaking the tablet if you find it difficult to swallow it whole.
The recommended dose is:
Adults:
The recommended dose to start treatment is 100 mg to 300 mg of alopurinol per day. The dose can be increased up to 900 mg per day, depending on each case. In this case, and if stomach upset appears, it is recommended to divide the dose into several intakes per day and take them with food.
Children and adolescents under 15 years
The usual dose of this medicine in children is 100 mg to 400 mg per day.
Elderly patients
Your doctor will recommend the lowest possible dose of alopurinol to achieve reduced uric acid levels and control your symptoms.
Patients with liver or kidney function impairment
If you have liver or kidney problems, your doctor will prescribe the lowest possible dose of alopurinol that achieves reduced uric acid levels and controls your symptoms. In case of kidney failure, your doctor may advise you to take less than 100 mg per day or tell you to take single doses of 100 mg at intervals greater than one day.
If you are on dialysis 2 or 3 times a week, your doctor may prescribe a dose of 300-400 mg immediately after each dialysis session.
If you take more Alopurinol Pensa than you should
In this case, consult the Toxicology Information Service, Telephone 91 562 04 20, or go to your doctor.
In case of accidental ingestion of too much medicine, go to your doctor without delay or to the emergency department of the nearest hospital. Bring this leaflet with you.
If you forget to take Alopurinol Pensa
Do not take a double dose to make up for forgotten doses.
If you forget to take a dose, take the next dose as soon as you remember. Then, continue as you usually do.
If you forget several doses, it is best to contact your doctor to decide what to do from that moment on.
If you stop taking Alopurinol Pensa:
Your doctor will indicate the duration of treatment with this medicine. Do not stop treatment before, even if you feel better.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The frequency of side effects is classified as:
Very common (at least 1 in 10 patients).
Common (at least 1 in 100 patients).
Uncommon (at least 1 in 1,000 patients).
Rare (at least 1 in 10,000 patients).
Very rare (less than 1 in 10,000 patients).
Frequency not known (cannot be estimated from the available data).
Infections and infestations:
Blood and lymphatic system disorders:
Sometimes, alopurinol tablets can cause effects on the blood that manifest with the appearance of more frequent bruising than usual, sore throat, or other signs of infection. These effects usually occur in people with kidney or liver problems. Inform your doctor as soon as possible if you have any of these symptoms.
Investigations:
Immune system disorders:
Very rarely, convulsions, wheezing (whistling), palpitations, chest tightness, or loss of consciousness can occur.
Metabolism and nutrition disorders:
Psychiatric disorders:
Nervous system disorders:
Eye disorders:
Ear and labyrinth disorders:
Cardiac disorders:
Vascular disorders:
Gastrointestinal disorders:
Hepatobiliary disorders:
Skin and subcutaneous tissue disorders:
Musculoskeletal and connective tissue disorders:
Renal and urinary disorders:
Reproductive system and breast disorders:
General disorders and administration site conditions:
If you experience any of the following symptoms, stop taking the medicine and inform your doctor immediately:
Rare (affect less than 1 in 1000 people)
There have been reports of fever with or without signs or symptoms of generalized hypersensitivity to alopurinol (see Immune system disorders).
Do not be alarmed by this list of side effects, as it is possible that none of them will appear in your case.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
No special storage conditions are required. Store in the original packaging.
Do not use this medicine after the expiration date that appears on the packaging after "EXP". The expiration date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Alopurinol Pensa:
The active ingredient is alopurinol. Each tablet contains 300 mg of alopurinol.
The other components (excipients) are: lactose, sodium croscarmellose, povidone K-30, and magnesium stearate.
Appearance of the Product and Packaging Contents:
Alopurinol Pensa are white, circular tablets, anonymous on one side and scored on the other, approximately 12 mm in diameter. Each package contains 30 or 500 (clinical package) tablets packaged in PVC/aluminum blisters.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer:
Towa Pharmaceutical Europe, S.L.
C/ de Sant Martí 75-97
08107 Martorelles (Barcelona)
Spain
Date of the Last Revision of this Leaflet:November 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ALOPURINOL PENSA 300 mg TABLETS in November, 2025 is around 2.81 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.